109 related articles for article (PubMed ID: 15548640)
1. On the importance of exposure variability to the doses of volatile organic compounds.
Rappaport SM; Kupper LL; Lin YS
Toxicol Sci; 2005 Feb; 83(2):224-36. PubMed ID: 15548640
[TBL] [Abstract][Full Text] [Related]
2. Variability of environmental exposures to volatile organic compounds.
Rappaport SM; Kupper LL
J Expo Anal Environ Epidemiol; 2004 Jan; 14(1):92-107. PubMed ID: 14726948
[TBL] [Abstract][Full Text] [Related]
3. Use of a physiologically based model to predict systemic uptake and respiratory elimination of perchloroethylene.
Dallas CE; Muralidhara S; Chen XM; Ramanathan R; Varkonyi P; Gallo JM; Bruckner JV
Toxicol Appl Pharmacol; 1994 Sep; 128(1):60-8. PubMed ID: 8079355
[TBL] [Abstract][Full Text] [Related]
4. Contribution of trichloroacetic acid to liver tumors observed in perchloroethylene (perc)-exposed mice.
Sweeney LM; Kirman CR; Gargas ML; Dugard PH
Toxicology; 2009 Jun; 260(1-3):77-83. PubMed ID: 19464572
[TBL] [Abstract][Full Text] [Related]
5. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.
Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED
J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363
[TBL] [Abstract][Full Text] [Related]
6. Intra-urban variability of air pollution in Windsor, Ontario--measurement and modeling for human exposure assessment.
Wheeler AJ; Smith-Doiron M; Xu X; Gilbert NL; Brook JR
Environ Res; 2008 Jan; 106(1):7-16. PubMed ID: 17961539
[TBL] [Abstract][Full Text] [Related]
7. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
[TBL] [Abstract][Full Text] [Related]
8. A dosimetric analysis of the acute behavioral effects of inhaled toluene in rats.
Bushnell PJ; Oshiro WM; Samsam TE; Benignus VA; Krantz QT; Kenyon EM
Toxicol Sci; 2007 Sep; 99(1):181-9. PubMed ID: 17548890
[TBL] [Abstract][Full Text] [Related]
9. The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene.
Covington TR; Robinan Gentry P; Van Landingham CB; Andersen ME; Kester JE; Clewell HJ
Regul Toxicol Pharmacol; 2007 Feb; 47(1):1-18. PubMed ID: 16901594
[TBL] [Abstract][Full Text] [Related]
10. Acute perchloroethylene exposure alters rat visual-evoked potentials in relation to brain concentrations.
Boyes WK; Bercegeay M; Oshiro WM; Krantz QT; Kenyon EM; Bushnell PJ; Benignus VA
Toxicol Sci; 2009 Mar; 108(1):159-72. PubMed ID: 19098276
[TBL] [Abstract][Full Text] [Related]
11. Delivery levels and behavior of 1,3-butadiene, acrylonitrile, benzene, and other toxic volatile organic compounds in mainstream tobacco smoke from two brands of commercial cigarettes.
Pankow JF; Luo W; Tavakoli AD; Chen C; Isabelle LM
Chem Res Toxicol; 2004 Jun; 17(6):805-13. PubMed ID: 15206901
[TBL] [Abstract][Full Text] [Related]
12. Reconstructing week-long exposures to volatile organic compounds using physiologically based pharmacokinetic models.
Roy A; Georgopoulos PG
J Expo Anal Environ Epidemiol; 1998; 8(3):407-22. PubMed ID: 9679220
[TBL] [Abstract][Full Text] [Related]
13. Toxicokinetics of inhaled trichloroethylene and tetrachloroethylene in humans at 1 ppm: empirical results and comparisons with previous studies.
Chiu WA; Micallef S; Monster AC; Bois FY
Toxicol Sci; 2007 Jan; 95(1):23-36. PubMed ID: 17032701
[TBL] [Abstract][Full Text] [Related]
14. Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: effects of concentration and duration.
Abraham K; Mielke H; Huisinga W; Gundert-Remy U
Arch Toxicol; 2005 Feb; 79(2):63-73. PubMed ID: 15565428
[TBL] [Abstract][Full Text] [Related]
15. A linear model relating breath concentrations to environmental exposures: application to a chamber study of four volunteers exposed to volatile organic chemicals.
Wallace L; Pellizzari E; Gordon S
J Expo Anal Environ Epidemiol; 1993; 3(1):75-102. PubMed ID: 8518547
[TBL] [Abstract][Full Text] [Related]
16. Assessing the impact of the duration and intensity of inhalation exposure on the magnitude of the variability of internal dose metrics in children and adults.
Valcke M; Krishnan K
Inhal Toxicol; 2011 Dec; 23(14):863-77. PubMed ID: 22084919
[TBL] [Abstract][Full Text] [Related]
17. Environmental and biological monitoring of volatile organic compounds in the workplace.
Caro J; Gallego M
Chemosphere; 2009 Oct; 77(3):426-33. PubMed ID: 19635627
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and health impacts of volatile organic compounds in photocopy centers.
Lee CW; Dai YT; Chien CH; Hsu DJ
Environ Res; 2006 Feb; 100(2):139-49. PubMed ID: 16045905
[TBL] [Abstract][Full Text] [Related]
19. [Biological monitoring of environmental benzene exposure in traffic wardens].
Buratti M; Pellegrino O; Valla C; Fustinoni S; Colombi A
Med Lav; 1997; 88(3):208-19. PubMed ID: 9379989
[TBL] [Abstract][Full Text] [Related]
20. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.
Yokley K; Tran HT; Pekari K; Rappaport S; Riihimaki V; Rothman N; Waidyanatha S; Schlosser PM
Risk Anal; 2006 Aug; 26(4):925-43. PubMed ID: 16948686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
